What is the typical dosing for mental health applications
As of time of publication, all further trials were happening in China with no phase 2 or 3 trials active anywhere else
Compounded drugs are not FDA-approved, and compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug
Prolonged Longevity: By diminishing the risk of complications linked to obesity, GLP-1 can potentially prolong an individuals lifespan and afford them more years of good health
Moran, Claus Aagaard Nielsen, Mikkel Due Petersen, Lars Nygaard, David rsted, Christian Poulsen, Tina Secher Rasmussen, and Else Marie Agger (Novo Nordisk A/S, Denmark) for review of and input to the manuscript, and to Alexander Jones, PhD, CMPP TM and Sola Neunie, MSc, CMPP TM from AXON Communications (supported by Novo Nordisk) for writing assisstance